[18F]JNJ-64511070

N/A

Report date: 2025/12/01 17:16:38
NME

Base Information

Drug Name[18F]JNJ-64511070
Drug Alias Name[18F]-JNJ-64511070
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionPositron-emission tomography enhancersVoltage-dependent calcium channel gamma-8 subunit binders
TargetsVoltage-dependent calcium channel gamma-8 subunit
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Research & Development Llc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A